Nuclear Receptor Coactivator 3 (NCoA-3) activators comprise a class of chemical compounds designed to interact with and modulate the activity of the NCoA-3 protein, also known as SRC-3 (Steroid Receptor Coactivator-3) or AIB1 (Amplified in Breast Cancer 1). NCoA-3 is a member of the nuclear receptor coactivator family and plays a pivotal role in the regulation of gene expression by acting as a coactivator for various nuclear receptors and transcription factors. These coactivators facilitate the assembly of transcriptional complexes, enhancing the transcriptional activity of target genes. NCoA-3, in particular, is involved in a wide range of physiological processes, including development, metabolism, and hormone signaling. Activators targeting NCoA-3 aim to influence its interactions with transcription factors, thereby modulating the transcriptional output of genes under its control.
The mechanism of action of NCoA-3 activators typically involves their binding to specific regions of the NCoA-3 protein, often within its interaction domains with transcription factors or other coactivators. By doing so, these compounds can either enhance or inhibit the coactivator function of NCoA-3, resulting in alterations in gene expression patterns. These changes in gene regulation can have broad-ranging effects on cellular processes and pathways, depending on the specific genes involved and the context in which NCoA-3 is active. Researchers are actively exploring the molecular details of NCoA-3 activation and its downstream effects to gain a deeper understanding of its role in various biological contexts, offering valuable insights into the intricacies of gene regulation and cellular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a phytoestrogen, indirectly activates NCoA-3 by binding to estrogen receptors, which NCoA-3 coactivates. | ||||||
3,3′-Diindolylmethane | 1968-05-4 | sc-204624 sc-204624A sc-204624B sc-204624C sc-204624D sc-204624E | 100 mg 500 mg 5 g 10 g 50 g 1 g | $37.00 $65.00 $89.00 $421.00 $681.00 $66.00 | 8 | |
3,3'-Diindolylmethane can influence NCoA-3 activity through its effects on estrogen metabolism and receptor signaling. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, potentially enhancing NCoA-3's coactivation function via cAMP-mediated pathways. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
As a primary estrogen, β-Estradiol directly engages estrogen receptors, with NCoA-3 serving as a coactivator, thereby enhancing its activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, may indirectly enhance NCoA-3 activity by altering chromatin structure and gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, can indirectly affect NCoA-3 activity through the PI3K/Akt pathway, which interacts with estrogen receptor signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, an MEK inhibitor, may influence NCoA-3 activity through the MAPK/ERK pathway, which is involved in the regulation of estrogen receptor function. | ||||||
ICI 182,780 | 129453-61-8 | sc-203435 sc-203435A | 1 mg 10 mg | $83.00 $187.00 | 34 | |
ICI 182,780, an estrogen receptor antagonist, can indirectly affect NCoA-3 activity by modulating estrogen receptor functions. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen, a selective estrogen receptor modulator, indirectly influences NCoA-3 activity by altering estrogen receptor signaling. | ||||||